PRRT2 and myasthenia gravis: Together, the data suggest that CatC enhanced NR2B expression and further induced the activation of Ca2+-dependent PKC/p38 MAPK/NF-κB pathway, leading to an increase in production and release of proinflammatory cytokines in MG.